Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Immunology Research|November 28, 2019
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV<sup>+</sup> CancersGabriele Galliverti, Stephan Wullschleger, Mélanie Tichet, et al.Cancer Cell|October 10, 2018
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to ChemotherapyTerry R Medler, Dhaarini Murugan, Wesley Horton, et al.Research Square|February 24, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.BMC Genomics|June 26, 2023
An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequencesBurcu Gurun, Wesley Horton, Dhaarini Murugan, et al.Molecular Cancer Research : MCR|April 5, 2022
T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62Colin J Daniel, Carl Pelz, Xiaoyan Wang, et al.Nature Immunology|February 28, 2023
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor controlMaria M Steele, Abhinav Jaiswal, Ines Delclaux, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2026
CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts anti-PD-1 Efficacy in Transgenic Mammary TumorsAmanda Poissonnier, Hope S Rugo, Wesley Horton, et al.Journal of Clinical Immunology|February 13, 2014
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantationDhaarini Murugan, Michael H Albert, Jörg Langemeier, et al.Blood|April 23, 2014
Inherited biallelic CSF3R mutations in severe congenital neutropeniaAlexa Triot, Päivi M Järvinen, Juan I Arostegui, et al.The New England Journal of Medicine|November 6, 2009
Inflammatory bowel disease and mutations affecting the interleukin-10 receptorErik-Oliver Glocker, Daniel Kotlarz, Kaan Boztug, et al.Pageof 2